Search Results - Habtension, A

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Early increase in ammonia is a feature of non-alcoholic fatty liver disease and the ammonia lowering drug, ornithine phenylacetate (OCR-002) prevents progression of fibrosis in a rodent model

    Early increase in ammonia is a feature of non-alcoholic fatty liver disease and the ammonia lowering drug, ornithine phenylacetate (OCR-002) prevents progression of fibrosis in a r... by De Chiara, F, Habtension, A, Davies, N, Andreola, F, Rombouts, K, Arias, N, Thomsen, K.L, Jalan, R

    Published in Journal of hepatology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    THU-389 - Early increase in ammonia is a feature of non-alcoholic fatty liver disease and the ammonia lowering drug, ornithine phenylacetate (OCR-002) prevents progression of fibrosis in a rodent model

    THU-389 - Early increase in ammonia is a feature of non-alcoholic fatty liver disease and the ammonia lowering drug, ornithine phenylacetate (OCR-002) prevents progression of fibro... by De Chiara, F., Habtension, A., Davies, N., Andreola, F., Rombouts, K., Arias, N., Thomsen, K.L., Jalan, R.

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Early Increase in Ammonia Is A Feature of Non-Alcoholic Fatty Liver Disease and the Ammonia Lowering Drug, Ornithine Phenylacetate (OCR002) Prevents Progression of Fibrosis in A Rodent Model

    Early Increase in Ammonia Is A Feature of Non-Alcoholic Fatty Liver Disease and the Ammonia Lowering Drug, Ornithine Phenylacetate (OCR002) Prevents Progression of Fibrosis in A Ro... by De Chiara, Francesco, Habtension, Abe, Davies, Nathan, Andreola, Fausto, Rombouts, Krista, Arias, Natalia, Thomsen, Karen Louise, Jalan, Rajiv

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: